Characteristic | Overall Series | NAFLD Patients | Controls | ||||||
---|---|---|---|---|---|---|---|---|---|
Carriers (n = 200) | Non-Carriers (n = 104) | P Value | Carriers (n = 102) | Non-Carriers (n = 37) | P Value | Carriers (n = 98) | Non-Carriers (n = 67) | P Value | |
Female, % | 94 (47.0) | 50 (48.1) | 0.858 | 48 (47.1) | 17 (45.9) | 0.907 | 46 (46.9) | 33 (49.3) | 0.770 |
Age, y | 60.40 ± 13.96 | 60.82 ± 13.73 | 0.801 | 60.37 ± 15.53 | 62.83 ± 16.14 | 0.399 | 60.42 ± 12.18 | 59.76 ± 12.29 | 0.735 |
BMI, kg/m2 | 24.68 ± 4.29 | 24.12 ± 3.57 | 0.255 | 27.01 ± 4.19 | 26.73 ± 2.86 | 0.702 | 22.27 ± 2.81 | 22.66 ± 3.02 | 0.397 |
ALT, U/L | 27.27 ± 22.09 | 23.65 ± 14.97 | 0.093 | 30.23 ± 17.19 | 29.25 ± 19.07 | 0.766 | 24.18 ± 25.97 | 19.92 ± 9.90 | 0.143 |
AST, U/L | 23.74 ± 11.88 | 23.19 ± 11.11 | 0.691 | 24.26 ± 8.57 | 24.12 ± 10.14 | 0.937 | 23.21 ± 14.57 | 22.50 ± 11.40 | 0.736 |
GGT, U/L | 36.88 ± 37.78 | 29.70 ± 20.29 | 0.032 | 40.72 ± 26.74 | 36.68 ± 25.92 | 0.411 | 32.88 ± 46.39 | 25.70 ± 15.16 | 0.156 |
ALP, U/L | 72.94 ± 20.38 | 70.80 ± 23.17 | 0.407 | 71.83 ± 15.31 | 68.90 ± 19.77 | 0.344 | 74.09 ± 24.61 | 72.08 ± 24.80 | 0.607 |
TG, mmol/L | 1.98 ± 1.20 | 1.56 ± 1.07 | 0.003 | 1.95 ± 1.34 | 1.83 ± 1.24 | 0.599 | 2.33 ± 0.72 | 1.35 ± 0.86 | 0.893 |
TC, mmol/L | 5.37 ± 1.40 | 4.58 ± 1.29 | < 0.001 | 5.42 ± 0.80 | 5.60 ± 0.88 | 0.254 | 4.09 ± 1.21 | 3.93 ± 1.46 | 0.002 |
HDL, mmol/L | 1.25 ± 0.29 | 1.25 ± 0.36 | 0.891 | 1.19 ± 0.21 | 1.21 ± 0.22 | 0.654 | 1.31 ± 0.34 | 1.29 ± 0.41 | 0.706 |
LDL, mmol/L | 3.28 ± 0.68 | 2.91 ± 0.68 | < 0.001 | 3.44 ± 0.59 | 3.32 ± 0.49 | 0.025 | 3.11 ± 0.77 | 3.09 ± 0.59 | 0.863 |
TBIL, umol/L | 12.83 ± 4.62 | 13.56 ± 5.18 | 0.209 | 12.79 ± 4.36 | 14.06 ± 5.31 | 0.180 | 12.87 ± 4.90 | 13.16 ± 4.98 | 0.708 |
FPG, mmol/L | 5.20 ± 1.70 | 4.91 ± 1.12 | 0.107 | 5.75 ± 2.14 | 5.30 ± 1.22 | 0.115 | 4.64 ± 0.71 | 4.65 ± 0.95 | 0.887 |